MGMT methylation: Is it time to embrace the shades of grey?
作者信息
Gan Hui K
机构信息
Cancer Therapies and Biology Group, and Centre for Research Excellence in Brain Cancer, Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia.
La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.
出版信息
Neurooncol Pract. 2023 Feb 3;10(2):111-112. doi: 10.1093/nop/npad003. eCollection 2023 Apr.
Abstract
摘要
相似文献
1
MGMT methylation: Is it time to embrace the shades of grey?O6-甲基鸟嘌呤-DNA甲基转移酶甲基化：是时候接受灰色地带了吗？
Neurooncol Pract. 2023 Feb 3;10(2):111-112. doi: 10.1093/nop/npad003. eCollection 2023 Apr.
2
Dentate gyrus supports slope recognition memory, shades of grey-context pattern separation and recognition memory, and CA3 supports pattern completion for object memory.齿状回支持斜率识别记忆、灰度-背景模式分离和识别记忆，而海马体CA3区支持物体记忆的模式完成。
Neurobiol Learn Mem. 2016 Mar;129:29-37. doi: 10.1016/j.nlm.2015.08.010. Epub 2015 Aug 28.
3
Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.弱 MGMT 基因启动子甲基化可为新诊断的胶质母细胞瘤患者带来显著的临床生存获益：一项回顾性队列研究。
J Neurooncol. 2020 Jan;146(1):55-62. doi: 10.1007/s11060-019-03334-5. Epub 2019 Nov 7.
4
Young Women's Perceptions of the Relationship in Fifty Shades of Grey.年轻女性对《五十度灰》中恋爱关系的看法。
J Womens Health (Larchmt). 2016 Feb;25(2):139-48. doi: 10.1089/jwh.2015.5318. Epub 2015 Nov 16.
5
MGMT promoter methylation in Peruvian patients with glioblastoma.秘鲁胶质母细胞瘤患者中MGMT启动子甲基化情况
Ecancermedicalscience. 2018 Feb 14;12:812. doi: 10.3332/ecancer.2018.812. eCollection 2018.
6
Methylation Is Associated with Human Papillomavirus Infection in Cervical Dysplasia: A Longitudinal Study.甲基化与宫颈发育异常中的人乳头瘤病毒感染相关：一项纵向研究。
J Clin Med. 2023 Sep 25;12(19):6188. doi: 10.3390/jcm12196188.
7
The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.子宫肉瘤和癌肉瘤中O6-甲基鸟嘌呤-DNA甲基转移酶基因的启动子甲基化与表达
Oncol Lett. 2012 Sep;4(3):551-555. doi: 10.3892/ol.2012.771. Epub 2012 Jun 22.
8
O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.血清和肿瘤DNA中的O6-甲基鸟嘌呤-DNA甲基转移酶甲基化可预测多形性胶质母细胞瘤对1,3-双（2-氯乙基）-1-亚硝基脲的反应，但不能预测对替莫唑胺加顺铂的反应。
Clin Cancer Res. 2003 Apr;9(4):1461-8.
9
Association of Promoter and Enhancer Methylation with Genetic Variants, Clinical Parameters, and Demographic Characteristics in Glioblastoma.胶质母细胞瘤中启动子和增强子甲基化与基因变异、临床参数及人口统计学特征的关联
Cancers (Basel). 2023 Dec 9;15(24):5777. doi: 10.3390/cancers15245777.
10
Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis.头颈部鳞状细胞癌中MGMT启动子的异常甲基化：一项荟萃分析。
PLoS One. 2016 Sep 22;11(9):e0163534. doi: 10.1371/journal.pone.0163534. eCollection 2016.
本文引用的文献
1
The predictive value of partial promoter methylation for IDH-wild-type glioblastoma patients.部分启动子甲基化对异柠檬酸脱氢酶野生型胶质母细胞瘤患者的预测价值。
Neurooncol Pract. 2022 Sep 10;10(2):126-131. doi: 10.1093/nop/npac070. eCollection 2023 Apr.
2
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review.MGMT 启动子甲基化检测预测替莫唑胺治疗胶质母细胞瘤患者的总生存期：一项基于 Cochrane 系统评价的综合荟萃分析。
Neuro Oncol. 2021 Sep 1;23(9):1457-1469. doi: 10.1093/neuonc/noab105.
3
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.MGMT 启动子甲基化检测对替莫唑胺治疗胶质母细胞瘤患者总生存期的预测价值。
Cochrane Database Syst Rev. 2021 Mar 12;3(3):CD013316. doi: 10.1002/14651858.CD013316.pub2.
4
Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.有安全边际的启动子甲基化临界值选择胶质母细胞瘤患者入组避免替莫唑胺治疗的临床试验：四项临床试验的汇总分析。
Clin Cancer Res. 2019 Mar 15;25(6):1809-1816. doi: 10.1158/1078-0432.CCR-18-3181. Epub 2018 Dec 4.
5
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.MGMT 启动子甲基化状态检测指导胶质母细胞瘤的治疗：基于新出现的证据和当前的挑战来改进方法。
Neuro Oncol. 2019 Feb 14;21(2):167-178. doi: 10.1093/neuonc/noy132.
6
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.短程放疗联合替莫唑胺治疗老年胶质母细胞瘤患者。
N Engl J Med. 2017 Mar 16;376(11):1027-1037. doi: 10.1056/NEJMoa1611977.
7
A randomized trial of bevacizumab for newly diagnosed glioblastoma.贝伐珠单抗治疗新诊断的胶质母细胞瘤的随机试验。
N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573.
8
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.替莫唑胺剂量密集疗法治疗新诊断的胶质母细胞瘤：一项随机 III 期临床试验。
J Clin Oncol. 2013 Nov 10;31(32):4085-91. doi: 10.1200/JCO.2013.49.6968. Epub 2013 Oct 7.
9
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.替莫唑胺化疗单独与单独放疗治疗老年恶性星形细胞瘤的比较：NOA-08 随机、3 期试验。
Lancet Oncol. 2012 Jul;13(7):707-15. doi: 10.1016/S1470-2045(12)70164-X. Epub 2012 May 10.
10
MGMT gene silencing and benefit from temozolomide in glioblastoma.MGMT基因沉默与胶质母细胞瘤对替莫唑胺的获益
N Engl J Med. 2005 Mar 10;352(10):997-1003. doi: 10.1056/NEJMoa043331.
Zotero 插件